BB Biotech AG : A Q1 2020 performance impacted by the pandemic
>Q1 performances - BB Biotech published its Q1 2020 results this morning. The holding company's share price fell by 14.8% in euro and 15.7% in Swiss franc over the quarter reflecting the sell-off in the markets following the impact of the COVID-19 pandemic (changes including the dividend payment). Over the same period, the portfolio's performance declined by 22% in Swiss francs, 20.1% in euro and 21.4% in dollars compared to a 10.3% (in dollars) decline in its benchm...Co.'s principal activity is to invest in biotechnology companies globally. The investments are held through its wholly-owned subsidiaries: Biotech Focus N.V., Biotech Invest N.V., Biotech Target N.V., and Biotech Growth N.V., all of which are located in Curacao. Co. acquires holdings in companies in the biotechnology growth market. The focus of the holdings is on quoted companies that are concentrating on the development and marketing of innovative medicines. For the selection of holdings, Co. relies on fundamental analysis by physicians and molecular biologists.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.